Cas 355013-43-3,5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine

355013-43-3

Post Buying Request

Basic information

Product Name: 5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine
Synonyms: 5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine
CAS NO:355013-43-3
Molecular Formula:
Molecular Weight: 449.35
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine(CAS DataBase Reference)
NIST Chemistry Reference: 5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine(355013-43-3)
EPA Substance Registry System: 5-(3-bromo-4-ethyl-anilino)-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine(355013-43-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 355013-43-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

355013-43-3 Suppliers

Recommended suppliers

355013-43-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 355013-43-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,0,1 and 3 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 355013-43:
(8*3)+(7*5)+(6*5)+(5*0)+(4*1)+(3*3)+(2*4)+(1*3)=113
113 % 10 = 3
So 355013-43-3 is a valid CAS Registry Number.

355013-43-3Upstream product

355013-43-3Downstream Products

355013-43-3Relevant academic research and scientific papers

Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase

-

, (2008/06/13)

The invention relates to pyridine derivatives of formula (I), wherein the substituents and symbols are defined as indicated in the description, processes for the preparation thereof, their usage in the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of angiogenesis, and pharmaceutical compositions containing such compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 355013-43-3